Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials.

ABSTRACT:

SUBMITTER: Zhu F 

PROVIDER: S-EPMC9135375 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature